X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (256) 256
Publication (5) 5
Newspaper Article (3) 3
Book / eBook (2) 2
Book Chapter (2) 2
Conference Proceeding (1) 1
Patent (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (80) 80
male (67) 67
middle aged (67) 67
female (66) 66
adult (61) 61
hematology (60) 60
index medicus (59) 59
aged (55) 55
transplantation (38) 38
oncology (36) 36
treatment outcome (35) 35
antineoplastic combined chemotherapy protocols - therapeutic use (26) 26
chemotherapy (24) 24
lymphomas (24) 24
prognosis (24) 24
retrospective studies (24) 24
hematology, oncology and palliative medicine (22) 22
hematopoietic stem cells (22) 22
adolescent (21) 21
aged, 80 and over (21) 21
cancer (20) 20
young adult (19) 19
stem cells (17) 17
analysis (16) 16
immunology (16) 16
risk factors (16) 16
therapy (16) 16
transplantation, autologous (16) 16
bone-marrow-transplantation (15) 15
disease-free survival (15) 15
combined modality therapy (14) 14
mortality (14) 14
rituximab (14) 14
survival (14) 14
survival rate (14) 14
survival analysis (13) 13
disease (12) 12
follow-up studies (12) 12
hematopoietic stem cell transplantation (12) 12
non-hodgkins-lymphoma (12) 12
recurrence (12) 12
antineoplastic agents - therapeutic use (11) 11
bone marrow (11) 11
busulfan (11) 11
cyclophosphamide (11) 11
cohort studies (10) 10
neoplasm staging (10) 10
relapse (10) 10
antibodies, monoclonal - therapeutic use (9) 9
cyclophosphamide - administration & dosage (9) 9
etoposide (9) 9
follicular lymphoma (9) 9
time factors (9) 9
transplantation conditioning - methods (9) 9
acute myeloid-leukemia (8) 8
antineoplastic combined chemotherapy protocols - adverse effects (8) 8
care and treatment (8) 8
hematopoietic stem cell transplantation - methods (8) 8
immunophenotyping (8) 8
lymphoma (8) 8
non-hodgkin's lymphoma (8) 8
pathology (8) 8
toxicity (8) 8
transplantation, homologous (8) 8
cytarabine - administration & dosage (7) 7
diseases (7) 7
doxorubicin - administration & dosage (7) 7
health aspects (7) 7
impact (7) 7
kaplan-meier estimate (7) 7
leukemia (7) 7
lymphoma, follicular - pathology (7) 7
radioimmunotherapy (7) 7
vincristine - administration & dosage (7) 7
antineoplastic combined chemotherapy protocols - administration & dosage (6) 6
autologous stem cell transplantation (6) 6
expression (6) 6
hematopoietic stem cell transplantation - mortality (6) 6
hodgkin disease - therapy (6) 6
lymphoma, non-hodgkin - drug therapy (6) 6
medical research (6) 6
medicine, experimental (6) 6
prednisone - administration & dosage (6) 6
proportional hazards models (6) 6
remission induction (6) 6
research (6) 6
t cells (6) 6
age factors (5) 5
antibodies, monoclonal, murine-derived (5) 5
autologous hematopoietic cell transplantation (5) 5
b-cell lymphoma (5) 5
biomarkers, tumor - metabolism (5) 5
biopsy (5) 5
busulfan - administration & dosage (5) 5
colony-stimulating factor (5) 5
comorbidity (5) 5
diagnosis (5) 5
etoposide - administration & dosage (5) 5
graft vs host disease - etiology (5) 5
granulocyte colony-stimulating factor - administration & dosage (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Human Pathology, ISSN 0046-8177, 2011, Volume 42, Issue 4, pp. 552 - 557
Summary We enumerated programmed death 1 (PD-1)-positive follicular helper T cells, a potentially important regulator of immune response, in the tumor... 
Pathology | Follicular lymphoma | PD-1 | Prognostic factors | SURVIVAL | BCL-2 PROTEIN | PATHOLOGY | HIGH NUMBERS | B7-H1 | BLOCKADE | EXPRESSION | CARCINOMA | T-CELLS | CLINICAL-SIGNIFICANCE | Immunohistochemistry | Antigens, CD - immunology | T-Lymphocytes, Regulatory - metabolism | Prognosis | Antigens, CD - biosynthesis | Tissue Array Analysis | Humans | Middle Aged | Male | T-Lymphocytes, Regulatory - immunology | Young Adult | T-Lymphocytes, Helper-Inducer - immunology | Aged, 80 and over | Adult | Female | Lymphocytes, Tumor-Infiltrating - metabolism | Antigens, Differentiation, Myelomonocytic - immunology | Macrophages - immunology | Apoptosis Regulatory Proteins - biosynthesis | Antigens, Differentiation, Myelomonocytic - biosynthesis | Apoptosis Regulatory Proteins - immunology | T-Lymphocytes, Helper-Inducer - metabolism | Lymphoma, Follicular - pathology | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Lymphoma, Follicular - mortality | Tumor Microenvironment - immunology | Macrophages - metabolism | Lymphoma, Follicular - immunology | Programmed Cell Death 1 Receptor | Aged | Biomarkers, Tumor - immunology | Lymphocytes, Tumor-Infiltrating - immunology | Lymphomas | T cells | Proteins | Immunology | Lymphocytes | Embargoes & blockades | Ligands | T cell receptors | Multivariate analysis | Risk factors
Journal Article
American Journal of Hematology, ISSN 0361-8609, 10/2017, Volume 92, Issue 10, pp. 989 - 996
International prognostic index (IPI) has remained the primary prognostic tool in diffuse large B cell lymphoma (DLBCL) for more than 20 years. Even though the... 
SURVIVAL | INTERNATIONAL PROGNOSTIC INDEX | R-CHOP | RITUXIMAB | NCCN-IPI | COHORT | HEMATOLOGY | CANCER | AGE | Doxorubicin - therapeutic use | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Dose-Response Relationship, Drug | Vincristine - administration & dosage | Female | Doxorubicin - administration & dosage | Prednisone - administration & dosage | Lymphoma, Large B-Cell, Diffuse - drug therapy | Prednisone - adverse effects | Comorbidity | Treatment Outcome | Drug-Related Side Effects and Adverse Reactions - epidemiology | Disease-Free Survival | Lymphoma, Large B-Cell, Diffuse - diagnosis | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Lymphoma, Large B-Cell, Diffuse - epidemiology | Vincristine - therapeutic use | Vincristine - adverse effects | Aged | Antibodies, Monoclonal, Murine-Derived - adverse effects | Doxorubicin - adverse effects | Prednisone - therapeutic use | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Medical research | Chemotherapy | Patient outcomes | Analysis | Medicine, Experimental | Aged patients | Lymphomas | Cancer | Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2008, Volume 26, Issue 3, pp. 447 - 454
Journal Article
Bone Marrow Transplantation, ISSN 0268-3369, 2019, Volume 54, Issue 10, pp. 1553 - 1561
High-dose chemotherapy followed by autologous hematopoietic cell transplantation (AHCT) is an effective salvage therapy for patients with relapsed... 
Autografts | Transplants & implants | Stem cell transplantation | Etoposide | Transplantation | Non-Hodgkin's lymphoma | Lymphoma | Survival | Hemopoiesis | Chemotherapy | Cyclophosphamide | Cytarabine | Stem cells | Melphalan | Lymphomas | Busulfan | Conditioning
Journal Article
Journal Article
Journal of Clinical Apheresis, ISSN 0733-2459, 12/2019, Volume 34, Issue 6, pp. 638 - 645
Background Obesity has implications for hematopoietic progenitor cell (HPC) mobilization, chemotherapy administration, and medication dosing. We analyzed the... 
hematopoietic progenitor cell mobilization | body mass index | autologous hematopoietic cell transplantation | Index Medicus
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 2992 - 2992
Abstract Introduction: Progress in the treatment of patients with classical Hodgkin lymphoma (cHL) depends on identifying methods to better risk-stratify... 
Journal Article
British Journal of Haematology, ISSN 0007-1048, 03/2015, Volume 168, Issue 6, pp. 811 - 819
Summary Belinostat is a pan‐histone deacetylase inhibitor with antitumour and anti‐angiogenic properties. An open label, multicentre study was conducted in... 
belinostat | peripheral T cell Lymphoma | mycosis fungoides | T cell lymphoma | histone deacetylase inhibitors | Mycosis fungoides | Peripheral T cell Lymphoma | Histone deacetylase inhibitors | Belinostat | HISTONE DEACETYLASE INHIBITOR | MULTICENTER | CARBOPLATIN | RESPONSE CRITERIA | CLINICAL-TRIAL | SOLID TUMORS | NON-HODGKINS-LYMPHOMAS | CLASSIFICATION | VORINOSTAT | BEXAROTENE | HEMATOLOGY | Recurrence | Humans | Hydroxamic Acids - adverse effects | Middle Aged | Histone Deacetylase Inhibitors - administration & dosage | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Lymphoma, T-Cell, Cutaneous - drug therapy | Young Adult | Antineoplastic Agents - adverse effects | Aged, 80 and over | Hydroxamic Acids - administration & dosage | Adult | Female | Lymphoma, T-Cell, Peripheral - drug therapy | Drug Administration Schedule | Treatment Outcome | Lymphoma, T-Cell, Cutaneous - pathology | Sulfonamides - therapeutic use | Lymphoma, T-Cell, Peripheral - pathology | Sulfonamides - adverse effects | Hydroxamic Acids - therapeutic use | Aged | Histone Deacetylase Inhibitors - therapeutic use | Infusions, Intravenous | Neoplasm Staging | Histone Deacetylase Inhibitors - adverse effects | Sulfonamides - administration & dosage | Antimitotic agents | Care and treatment | Relapse | Clinical trials | Skin | Non-Hodgkin's lymphomas | Antineoplastic agents | T cells | Diseases
Journal Article
American Journal of Hematology, ISSN 0361-8609, 10/2017, Volume 92, Issue 10, pp. 989 - 996
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 4755 - 4755
Abstract The spectrum of infectious complications occurring in the first 100 days in lymphoma patients undergoing AHCT has not been well described in the... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 4202 - 4202
Abstract Introduction Post-transplant lymphoproliferative disorders (PTLD) are mostly Epstein-Barr virus (EBV) positive lymphoid proliferations resulting from... 
Journal Article
Veterinary Clinical Pathology, ISSN 0275-6382, 12/2016, Volume 45, Issue 4, pp. 665 - 668
Background The measurement of osmolality is of interest in several clinical conditions and has been investigated in multiple veterinary studies. However, the... 
temperature | storage | Clinical biochemistry | osmolarity | tonicity | PLASMA | DOGS | VETERINARY SCIENCES | GLYCOL | FORMULAS | GRAVITY | Temperature | Animals | Osmolar Concentration | Time Factors | Urine - chemistry | Specimen Handling - veterinary | Dogs - blood | Freezing | Serum - chemistry
Journal Article
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 1860 - 1860
Abstract Background: International Prognostic Index (IPI) has been used as the primary prognostic tool in diffuse large B cell lymphoma (DLBCL) for more than... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2002, Volume 20, Issue 10, pp. 2453 - 2463
Journal Article